Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Cellebrite DI's accounts receivables for the quarter that ended in Jun. 2026 was $110.8 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Cellebrite DI's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 77.09.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Cellebrite DI's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was $0.29.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Cellebrite DI's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Cellebrite DI's accounts receivable are only considered to be worth 75% of book value:
Cellebrite DI's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Cellebrite DI Accounts Receivable Related Terms
Cellebrite DI Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Cellebrite DI's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of $110.8 Mil mean?
Cellebrite DI (CLBT) has a Accounts Receivable of $110.8 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Cellebrite DI and its competitors.
Is Cellebrite DI's Accounts Receivable too high?
Cellebrite DI's current Accounts Receivable is $110.8 Mil. Overall, Cellebrite DI has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Accounts Receivable compare to TENB and PAY?
Cellebrite DI's Accounts Receivable of $110.8 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Software company?
A good Accounts Receivable depends on the Software industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Cellebrite DI and its competitors. Cellebrite DI's current Accounts Receivable is $110.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.32, compared to a current price of $11.63 — trading 28.7% below its estimated fair value. The current Accounts Receivable is $110.8 Mil. Cellebrite DI's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current Accounts Receivable is $110.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cellebrite DI (CLBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued.
The current stock price of $11.63 is trading 28.7% below its estimated GF Value™ of $16.32.
GuruFocus considers Cellebrite DI to be Modestly Undervalued.
Key valuation signals for CLBT:
Accounts Receivable: $110.8 Mil
GF Value™: $16.32 vs. price of $11.63 (28.7% below fair value)
No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
81GF Score
Get the complete analysis for CLBT
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLBT has been successfully added to your 
